Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||
| Net Income | -27,029 | -13,081 | -38,049 |
| Depreciation Amortization | -18 | 53 | 146 |
| Accounts payable and accrued liabilities | 12 | -1,563 | N/A |
| Other Working Capital | 1,993 | -1,198 | 4,062 |
| Other Operating Activity | 1,429 | 2,271 | 1,681 |
| Operating Cash Flow | $-23,613 | $-13,518 | $-32,160 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -55,780 | -39,653 | N/A |
| PPE Investments | -12 | -65 | -1,206 |
| Other Investing Activity | 0 | 0 | 19,065 |
| Investing Cash Flow | $-55,792 | $-39,718 | $17,859 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 4 | 0 | N/A |
| Common Stock Repurchased | -6 | N/A | N/A |
| Other Financing Activity | 29,591 | -1,448 | 103,254 |
| Financing Cash Flow | $29,589 | $-1,448 | $103,254 |
| Beginning Cash Position | 105,305 | 105,305 | 16,352 |
| End Cash Position | 55,489 | 50,621 | 105,305 |
| Net Cash Flow | $-49,816 | $-54,684 | $88,953 |
| Free Cash Flow | |||
| Operating Cash Flow | -23,613 | -13,518 | -32,160 |
| Capital Expenditure | -12 | -65 | N/A |
| Free Cash Flow | -23,625 | -13,583 | -32,160 |